stockrow
Saturday 14 November 2026
Export BRSHF’s income statement to Excel — free account
Bruush Oral Care Inc.
BRSHFConsumer Defensive Household & Personal Products
0.00
0.00
NaN
Follow BRSHF
Alert me
| Apr '23 | Mar '23 | Jan '23 | Dec '22 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | — | — |
+6 more quarters Free account |
P/S ratio |
1.68 | 1.23 | — | — | |
P/FCF ratio |
0.00 | 0.00 | — | — | |
P/Operating CF |
(0.62) | (0.45) | — | — | |
P/B ratio |
0.00 | 0.00 | — | — | |
Price to Tangible BV |
0.00 | 0.00 | — | — | |
EV/Sales |
2.91 | 2.48 | — | — | |
EV/EBITDA |
0.00 | 0.00 | — | — | |
EV/Operating CF |
(0.53) | (3.07) | — | — | |
EV/FCF |
(0.53) | (3.08) | — | — | |
Quick Ratio |
0.06 | 0.06 | 0.10 | 0.10 | |
Current Ratio |
0.15 | 0.15 | 0.46 | 0.46 | |
Net Debt/EBITDA |
(1.35) | (1.35) | 0.00 | 0.00 | |
Debt/Assets |
262.26% | 262.18% | 0.00% | 0.00% | |
Debt/Equity |
(0.45) | (0.45) | 0.00 | 0.00 | |
Asset Turnover |
1.67 | 1.65 | 0.00 | 0.00 | |
Operating CF/Net income |
9.99 | 9.99 | 0.00 | 0.00 | |
Capex/Depreciation |
(0.67) | (0.67) | 0.00 | 0.00 | |
Interest Coverage |
(7.22) | (7.23) | — | — | |
Research and Development Expense of Revenue |
0.46% | 0.46% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
398.92% | 562.58% | — | — | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | — | — | |
Graham Net Nets |
(1.77) | (2.44) | — | — | |
Graham Number |
81.65 | 0.00 | — | — | |
Earnings Yield |
(485.55%) | (485.55%) | — | — | |
Free Cash Flow Yield |
(323.81%) | (65.38%) | — | — | |
Revenue per Share |
0.65 | 0.00 | — | — | |
Operating CF per Share |
(9.52) | 0.00 | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(9.52) | 0.00 | 0.00 | 0.00 | |
Cash per Share |
0.39 | 0.00 | 0.00 | 0.00 | |
Shareholders Equity per Share |
(10.38) | 0.00 | 0.00 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | — | — | |
Book value per Share |
(10.38) | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(4.75) | (4.75) | 0.00 | 0.00 | |
Working Capital |
(5.18) | (5.18) | (1.41) | (1.41) | |
Capital Expenditures |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Current Asset Value |
(5.18) | (5.18) | (1.41) | (1.41) | |
EV/EBIT |
0.00 | 0.00 | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
0.00 | 0.00 | — | — | |
| Other line items | |||||
Average Receivables |
0.16 | 0.16 | 0.14 | — | |
Average Payables |
1.83 | 1.83 | 1.90 | — | |
Average Inventory |
0.19 | 0.19 | 0.30 | — | |
Average Assets |
1.04 | 1.04 | 0.60 | 0.60 | |
Average Common Equity |
(3.29) | (3.29) | (5.06) | — |
Columns are period end dates · fundamentals updated 26 Oct 2026